✦ LIBER ✦

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer

✍ Scribed by Claus-Henning Köhne; Ralf Hofheinz; Laurent Mineur; Henry Letocha; Richard Greil; Josef Thaler; Eva Fernebro; Erick Gamelin; Lucy DeCosta; Meinolf Karthaus

Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 584 KB
Volume: 138
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-011-1061-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simvastatin plus irinotecan, 5-fluoroura

Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study

✍ Jeeyun Lee; Kyung Hae Jung; Young Suk Park; Joong Bae Ahn; Sang Jun Shin; Seock- 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 284 KB

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF

Phase I study of gefitinib, irinotecan,

Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer

✍ Jeffrey A. Meyerhardt; Jeffrey W. Clark; Jeffrey G. Supko; Joseph P. Eder; Shuji 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 329 KB

A multicenter phase II study of irinotec

A multicenter phase II study of irinotecan (CPT-11) alternated with 5-fluorouracil and leucovorin as first-line treatment of patients with metastatic colorectal cancer

✍ JuanJosé Reina; Jorge Aparicio; Javier Salvador; JoséMaríaPuerto Pica; Antonio R 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 192 KB

Modified irinotecan plus bolus 5-fluorou

Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan

✍ Mitsukuni Suenaga; Nobuyuki Mizunuma; Daigo Shouji; Eiji Shinozaki; Satoshi Mats 📂 Article 📅 2008 🏛 Springer Japan 🌐 English ⚖ 235 KB

Gene expression of ferredoxin reductase

Gene expression of ferredoxin reductase predicts outcome in patients with metastatic colorectal cancer treated by 5-fluorouracil plus leucovorin

✍ Wataru Ichikawa; Akio Ooyama; Etsuko Toda; Yoshikazu Sugimoto; Toshinori Oka; Ta 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 317 KB